RxSight, Inc.
Ticker: 1111485
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 30.89+1.8% | 30.34-9.8% | 33.64-11.2% | 37.90+7.3% | 35.31+1.2% | 34.89+18.2% | 29.51+32.9% | 22.20 |
| Total Income | 30.89+1.8% | 30.34-9.8% | 33.64-11.2% | 37.90+7.3% | 35.31+1.2% | 34.89+18.2% | 29.51+32.9% | 22.20 |
| EXPENSES | ||||||||
| Expenditure | 48.72+14.6% | 42.52-10.7% | 47.64-1.9% | 48.57+9.0% | 44.54+3.1% | 43.22+7.6% | 40.18+15.8% | 34.71 |
| Tax | 0.01+0.0% | 0.01-66.7% | 0.03+50.0% | 0.02+100.0% | 0.01-50.0% | 0.02+100.0% | 0.01+0.0% | 0.01 |
| PROFIT | ||||||||
| PBT | -15.88-61.9% | -9.81+16.5% | -11.75-43.8% | -8.17-29.1% | -6.33-4.5% | -6.06+33.3% | -9.09+26.7% | -12.40 |
| Net Profit | -15.88-61.7% | -9.82+16.7% | -11.79-44.0% | -8.19-29.2% | -6.34-4.3% | -6.08+33.2% | -9.10+26.7% | -12.42 |
| KEY METRICS | ||||||||
| OPM % | -57.71%-17.57pp | -40.14%+1.49pp | -41.63%-13.46pp | -28.17%-2.04pp | -26.13%-2.24pp | -23.89%+12.27pp | -36.16%+20.21pp | -56.36% |
| NPM % | -51.42%-19.06pp | -32.35%+2.69pp | -35.04%-13.43pp | -21.61%-3.66pp | -17.95%-0.52pp | -17.43%+13.41pp | -30.84%+25.09pp | -55.93% |
| EPS | -0.38-58.3% | -0.24+17.2% | -0.29-45.0% | -0.20-25.0% | -0.16+0.0% | -0.16+36.0% | -0.25+28.6% | -0.35 |
Corporate Events
Board MeetingRXST
202616Jun
Board Meeting
Annual Meeting of Stockholders to elect Class II Directors, …
SEC Filing ↗